September 2011 • BioProcess International Vaccine Supplement
Pseudomonas fluorescens Expression Technology for Subunit Vaccine Production and Development
July 2011 • Genetic Engineering & Biotechnology News
Achieving Optimal Expression for Fabs
July 2011 • Genetic Engineering & Biotechnology News
Nudging Difficult-to-Express Proteins- Emerging Solutions Aim to Bring Challenging Targets Under Control
June 2011 • Innovations in Pharmaceutical Technology
A Toolbox for Protein Expression Scientists
June 2011 • Life Science Leader
Maximizing Pipeline Value and Operational Efficiency through High Throughput Protein Expression
November, 2010 • Bioprocess International
Modeling BioProcess Costs, Process Economic Benefits of Expression Technology based on Pseudomonas fluorescens
August, 2010 • Next Generation Pharma
The Real Value Driver
June, 2010 • Genetic Engineering & Biotechnology News
Pharmaceuticals: Cash Injection for Biologic Drugs
February • Chemical Week News
Pharmaceuticals: Cash Injection for Biologic Drugs
January • BioCentury, The Bernstein Report on BioBusines
Pfenex: Pfaster Protein Production
Posters and Presentations
October 2011
Development and Preclinical Optimization of a Circumsporozoite Protein (rCSP) Vaccine Candidate Against Malaria Via A Virtual Pharmaceutical Approach
Scott Winram
SAIC
September 2011
Get There Faster With Pfenex
September 2011
Why Sourcing Makes More Sense
May 2011 • PEGS
Boehringer Ingelheim Presents- Expression of an Antibody Fragment Utlizing the Pfēnex Expression Technology™ Platform
George Klima- Head Process Scientist Austria
Boehringer Ingelheim
March 2011 • ACS-BIOT
Expeditious Strain and Fermentation Development for Quality Recombinant Protein Production in Pseudomonas fluorescens
Lawrence Chew- Director, Fermentation Development
Pfenex Inc.
March 2011 • ACS-BIOT
Purification of Vaccine Antigens & Carriers Expressed in Pseudomonas fluorescens
Jerry Ngai- Scientist
Pfenex Inc.
Janauary 2011 • Peptalk
Rapid Production of High Quality Protein Enabled by Pfēnex Expression Technology™
Diane Retallack- Director, Molecular Biology
Pfenex Inc.
Janauary 2011 • Peptalk
Soluble Periplasmic Production of Human Granulocyte Colony-Stimulating Factor (G-CSF) in Pseudomonas fluorescens
Hongfan Jin*, Greg T. Cantin, Steven Maki, Lawrence Chew, Jerry Ngai and Diane M. Retallack- Pfenex Inc.
August 2010 • Recovery of Biologics
Novel Extraction and Purification of an Insoluble Protein without Refolding
Anant Patkar*, Ping-Hua Feng, Keith Haney, Lawrence Chew, Lei Lei Sengchanthalangsy, Greg Cantin, Jeff Allen- Pfenex Inc.